Filter by: patients
Home > Community Treatment Reports and Side Effects > Candesartan Treatment Report
What is Candesartan?

Candesartan cilexetil is an angiotensin receptor blocker (ARB), indicated for the treatment of patients with hypertension and patients with chronic heart failure (CHF) and left ventricular systolic dysfunction.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Elevated blood pressure 17 3 Efficacy_major
Hypertension 7 2 Efficacy_moderate
Other 6 0
Reduce Heart Pressures 2 0
General health 2 0
Support heart health 2 0

See all 42 patients currently taking Candesartan

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 6

Reported Dosages

  4 mg daily 8 mg daily 16 mg-12.5 mg daily 16 mg daily 32 mg daily
  9 Number of Patients: 9 9 Number of Patients: 9 1 Number of Patients: 1 15 Number of Patients: 15 8 Number of Patients: 8  

Reported Stop Reasons

Why Patients Stopped Taking Candesartan (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense 1   Expense: 100%

See all 1 patient who’ve stopped taking Candesartan

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Candesartan

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Candesartan

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Candesartan

Always
 5 83%
Usually
 1 17%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Candesartan

Very
 1 17%
Somewhat
 0 0%
A little
 0 0%
Not at all
 5 83%

Cost

Paid out of pocket

Cost of Candesartan

$200+
 0 0%
$100-199
 0 0%
$50-99
 1 100%
$25-49
 0 0%
< $25
 0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.